Pharmaceutical Compositions Comprising Multi-Component Crystalline Particles Suitable for Use in Inhalation Therapy
First Claim
1. A composition for inhalation therapy comprising multi-component crystalline particles and also particles of fluticasone propionate, wherein the multi-component crystalline particles comprise glycopyrronium bromide and salmeterol xinafoate (GB-SX) as active ingredients and are substantially free of excipients and agents other than the active ingredients.
3 Assignments
0 Petitions
Accused Products
Abstract
Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy and for delivery by oral or nasal inhalation are provided, wherein said compositions additionally comprise particles of at least one additional active agent. Also provided are methods of preparation of the compositions and their use in medicine.
-
Citations
23 Claims
- 1. A composition for inhalation therapy comprising multi-component crystalline particles and also particles of fluticasone propionate, wherein the multi-component crystalline particles comprise glycopyrronium bromide and salmeterol xinafoate (GB-SX) as active ingredients and are substantially free of excipients and agents other than the active ingredients.
-
3. (canceled)
-
5-11. -11. (canceled)
-
19. (canceled)
-
21. (canceled)
Specification